📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy (2023)

First Author: Miller D

Attributed to: Discovery of ERK5 inhibitors for biomarker-driven clinical evaluation in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.3c00072

PubMed Identifier: 37002872

Publication URI: http://europepmc.org/abstract/MED/37002872

Type: Journal Article/Review

Parent Publication: Journal of Medicinal Chemistry

Issue: 7

ISSN: 0022-2623